Skip to main content
Log in

Comparison of Magnetic Resonance Enterography Global Score (MEGS) with indices of Crohn’s disease activity in South Asian population

  • Hollow Organ GI
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

Assessment of disease activity in Crohn’s helps predict important clinical outcomes. Among the various modalities available to assess disease activity, magnetic resonance enterography (MRE) is considered a safe and reliable imaging option. Various MRE-based scoring systems have been developed to measure disease activity, one of which being the MRE global score (MEGS). We aimed to correlate MEGS with some of the important indices of Crohn’s disease activity.

Methodology

Crohn’s disease patients referred for MRE were included in the study. Along with demographic profile and relevant investigations, MRE parameters related to MEGS were also assessed.

Result

A total of 47 patients were recruited for the study. Their median age was 34 years (range 18–68 years), and male:female ratio was 16:31. There was modest positive correlation between MEGS and faecal calprotectin (r = 0.3, p = 0.04), CRP level (r = 0.34, p = 0.02) and Harvey Bradshaw index (r = 0.3, p = 0.043), respectively. However, there was strong correlation between segmental MEGS and Simple Endoscopic Score in those with terminal ileal disease (r = 0.81, p < 0.001). Mural thickness was the only MRE parameter that correlated with active disease (OR − 1.35, 95% CI 1.01, 1.81, p = 0.041) on multivariate analysis. There was moderate inter-observer agreement (Lin’s r = 0.78, p < 0.001).

Conclusion

MEGS showed modest correlation with indices of Crohn’s disease activity which corroborates the complementary role of MRE in management of such patients.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn’s disease. The Lancet. 2017;389(10080):1741–55.

    Article  Google Scholar 

  2. Peyrin-Biroulet L, Reinisch W, Colombel J-F, Mantzaris GJ, Kornbluth A, Diamond R, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut. 2014;63(1):88–95.

    Article  Google Scholar 

  3. D’Incà R, Caccaro R. Measuring disease activity in Crohn’s disease: what is currently available to the clinician. Clin Exp Gastroenterol. 2014;7:151–61.

    Article  Google Scholar 

  4. Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. IID. 2017;2(2):102–15.

    PubMed  PubMed Central  Google Scholar 

  5. Steward MJ, Punwani S, Proctor I, Adjei-Gyamfi Y, Chatterjee F, Bloom S, et al. Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2012;81(9):2080–8.

    Article  Google Scholar 

  6. Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58(8):1113–20.

    Article  CAS  Google Scholar 

  7. Makanyanga JC, Pendsé D, Dikaios N, Bloom S, McCartney S, Helbren E, et al. Evaluation of Crohn’s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol. 2014;24(2):277–87.

    Article  Google Scholar 

  8. Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn’s and Colitis. 2019;13(2):144-164K.

    Article  Google Scholar 

  9. Satsangi J, Silverberg MS, Vermeire S, Colombel J. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–53.

    Article  CAS  Google Scholar 

  10. Vermeire S, Schreiber S, Sandborn WJ, Dubois C, Rutgeerts P. Correlation between the Crohn’s disease activity and Harvey-Bradshaw indices in assessing Crohn’s disease severity. Clin Gastroenterol Hepatol. 2010;8(4):357–63.

    Article  Google Scholar 

  11. Daperno M, D’Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–12.

    Article  Google Scholar 

  12. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119(1):15–22.

    Article  CAS  Google Scholar 

  13. Bjarnason I. The Use of Fecal Calprotectin in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017;13(1):53–6.

    Google Scholar 

  14. Lin J-F, Chen J-M, Zuo J-H, Yu A, Xiao Z-J, Deng F-H, et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis. 2014;20(8):1407–15.

    Article  Google Scholar 

  15. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn’s disease. AJR Am J Roentgenol. 1996;167(1):3–15.

    Article  CAS  Google Scholar 

  16. Umschaden HW, Gasser J. MR enteroclysis. Radiologic Clinics of North America. 2003;41(2):231–48.

    Article  Google Scholar 

  17. Best WR. Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis. 2006;12(4):304–10.

    Article  Google Scholar 

  18. Macarini L, Stoppino LP, Centola A, Muscarella S, Fortunato F, Coppolino F, et al. Assessment of activity of Crohn’s disease of the ileum and large bowel: proposal for a new multiparameter MR enterography score. Radiol Med. 2013;118(2):181–95.

    Article  CAS  Google Scholar 

  19. Sempere GAJ, Martinez Sanjuan V, Medina Chulia E, Benages A, Tome Toyosato A, Canelles P, et al. MRI evaluation of inflammatory activity in Crohn’s disease. AJR Am J Roentgenol. 2005;184(6):1829–35.

    Article  Google Scholar 

  20. Röttgen R, Herzog H, Lopez-Häninnen E, Felix R. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn’s disease. Clin Imaging. 2006;30(1):27–31.

    Article  Google Scholar 

  21. Bellini D, Rivosecchi F, Panvini N, Rengo M, Caruso D, Carbone I, et al. Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis. World J Gastroenterol. 2019;25(31):4555–66.

    Article  Google Scholar 

  22. Papay P, Ignjatovic A, Karmiris K, Amarante H, Milheller P, Feagan B, et al. Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis. 2013;7(8):653–69.

    Article  Google Scholar 

  23. Scardapane A, Ambrosi A, Salinaro E, Mancini ME, Principi M, Di Leo A, et al. Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score. Gastroenterology Research and Practice. 2015;2015:e159641.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Dr. Mahasampath Gowri, from the Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India for her help with statistical analysis.

Funding

Institutional fluid research grant.

Author information

Authors and Affiliations

Authors

Contributions

This work was done as part of Dr. Susanna K Jose’s thesis requirement for MD Radiodiagnosis Degree Examination of the Tamil Nadu Dr. M.G.R Medical University, Chennai (May 2020).

Corresponding author

Correspondence to Betty Simon.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest to disclose.

Ethical approval

The study was approved by the institutional review board and Ethics committee. Informed consent was obtained from all participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 KB)

Supplementary file2 (DOCX 14 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jose, S.K., Simon, B., Simon, E.G. et al. Comparison of Magnetic Resonance Enterography Global Score (MEGS) with indices of Crohn’s disease activity in South Asian population. Abdom Radiol 47, 547–553 (2022). https://doi.org/10.1007/s00261-021-03381-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-03381-5

Keywords

Navigation